DOX vs. EPAM, CTSH, HCP, AZPN, PRFT, VRSN, ZS, WIT, CDAY, and PCTY
Should you be buying Amdocs stock or one of its competitors? The main competitors of Amdocs include EPAM Systems (EPAM), Cognizant Technology Solutions (CTSH), HashiCorp (HCP), Aspen Technology (AZPN), Perficient (PRFT), VeriSign (VRSN), Zscaler (ZS), Wipro (WIT), Ceridian HCM (CDAY), and Paylocity (PCTY). These companies are all part of the "computer and technology" sector.
EPAM Systems (NYSE:EPAM) and Amdocs (NASDAQ:DOX) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, community ranking, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.
In the previous week, EPAM Systems had 9 more articles in the media than Amdocs. MarketBeat recorded 14 mentions for EPAM Systems and 5 mentions for Amdocs. EPAM Systems' average media sentiment score of 1.28 beat Amdocs' score of -0.07 indicating that Amdocs is being referred to more favorably in the news media.
EPAM Systems currently has a consensus target price of $282.81, indicating a potential upside of 50.59%. Amdocs has a consensus target price of $104.83, indicating a potential upside of 28.24%. Given Amdocs' higher probable upside, equities analysts plainly believe EPAM Systems is more favorable than Amdocs.
Amdocs received 18 more outperform votes than EPAM Systems when rated by MarketBeat users. However, 73.68% of users gave EPAM Systems an outperform vote while only 72.42% of users gave Amdocs an outperform vote.
Amdocs has higher revenue and earnings than EPAM Systems. Amdocs is trading at a lower price-to-earnings ratio than EPAM Systems, indicating that it is currently the more affordable of the two stocks.
Amdocs has a net margin of 10.62% compared to Amdocs' net margin of 9.28%. EPAM Systems' return on equity of 17.85% beat Amdocs' return on equity.
EPAM Systems has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500. Comparatively, Amdocs has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500.
91.6% of EPAM Systems shares are owned by institutional investors. Comparatively, 92.0% of Amdocs shares are owned by institutional investors. 4.3% of EPAM Systems shares are owned by insiders. Comparatively, 15.4% of Amdocs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
EPAM Systems and Amdocs tied by winning 9 of the 18 factors compared between the two stocks.
Get Amdocs News Delivered to You Automatically
Sign up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
